COMMUNIQUÉ DE PRESSE Inventiva invited to present at the 37th Annual J.P. Morgan COMMUNIQUÉ DE PRESSE Healthcare Conference Daix (France), December 10, 2018 - Inventiva S.A. ("Inventiva" or the "Company"), a biopharmaceutical company developing innovative therapies in nonalcoholic steatohepatitis (NASH), systemic sclerosis (SSc) and mucopolysaccharidosis (MPS), today announced that Frédéric Cren, Chairman, CEO and cofounder of Inventiva, has been invited to present a corporate overview, followed by a Q&A session, at the upcoming 37th Annual J.P. Morgan Annual Healthcare Conference, being held on January 7-10, 2019 at the Westin St. Francis Hotel in San Francisco,...
|
